SAA2: A Potential Drug Target Or Biomarker (G6289)

Target Name: SAA2

NCBI ID: G6289

SAA2

SAA2: A Potential Drug Target Or Biomarker

SAA2 (SAA2_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle. It is a member of the SAA family of proteins, which are involved in various cellular processes, including cell signaling, DNA replication, and metabolism. SAA2 has been identified as a potential drug target or biomarker due to its unique structure and the involvement of multiple cellular processes.

SAA2 is a transmembrane protein that is involved in several different cellular processes. It is expressed in the brain and is thought to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease. It is also expressed in the heart and is involved in the regulation of cardiac contractions and the maintenance of heart health. In addition, SAA2 is expressed in the liver and is involved in the metabolism of drugs and other substances that are harmful to the liver.

One of the key features of SAA2 is its role in the regulation of DNA replication. DNA replication is a critical process that is essential for the growth and development of all living organisms. SAA2 is involved in the regulation of DNA replication by binding to the enzyme DNAL, which is involved in the replication of DNA in the cell. This interaction between SAA2 and DNAL allows for the regulation of DNA replication and the maintenance of genetic information in the cell.

In addition to its role in DNA replication, SAA2 is also involved in the regulation of cell signaling. It is a member of the SAA family of proteins, which are involved in the regulation of various cellular processes, including cell signaling. SAA2 is thought to play a role in the regulation of cell signaling by binding to the enzyme SIRT1, which is involved in the detoxification of harmful substances in the cell. This interaction between SAA2 and SIRT1 allows for the regulation of cell signaling and the maintenance of cellular health.

SAA2 is also involved in the regulation of metabolism. It is expressed in the liver and is involved in the metabolism of drugs and other substances that are harmful to the liver. This interaction between SAA2 and metabolism allows for the regulation of metabolism and the maintenance of cellular health.

In conclusion, SAA2 is a protein that is involved in various cellular processes and has been identified as a potential drug target or biomarker. Its unique structure and involvement in multiple cellular processes make it an attractive target for research and development of new treatments for a variety of diseases. Further research is needed to fully understand the role of SAA2 in cellular processes and its potential as a drug target.

Protein Name: Serum Amyloid A2

Functions: Major acute phase reactant

The "SAA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SAA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets